SCHEMBL4853418

SCHEMBL4853418

Cc1sc(S(=O)(=O)O)cc1N

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.34
HSD17B10 Q99714 4/20 0.34
NT5E P21589 2/20 0.32
TSHR P16473 3/20 0.31
TDP1 Q9NUW8 1/20 0.31
BRD4 O60885 1/20 0.31
TP53 P04637 1/20 0.31
CREBBP Q92793 1/20 0.31
CASP6 P55212 2/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
GAA P10253 3/20 0.31
KDM4E B2RXH2 2/20 0.31
MAPT P10636 2/20 0.31
MEN1 O00255 1/20 0.31
PKM P14618 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP3A4 P08684 1/20 0.31
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1938915 0.81 CA2 (0.43) ALDH1A1KDM4E
SCHEMBL4852760 0.77 ALDH1A1 (0.39) ALDH1A1HSD17B10NT5ETSHRTDP1
Hydrochloric Acid SCHEMBL11048859 0.77 MAPT (0.42) ALDH1A1HSD17B10TP53GAAKDM4E
SCHEMBL1939237 0.70 ALDH1A1 (0.40) ALDH1A1TP53GAAKDM4EMAPT
SCHEMBL4851474 0.69 GPR35 (0.40) ALDH1A1HSD17B10TSHRTDP1CASP6
SCHEMBL13783603 0.67 DAO (0.47)
Methane SCHEMBL11877352 0.67 ALDH1A1 (0.34) ALDH1A1HSD17B10NT5ETSHRTDP1
SCHEMBL5182933 0.67 ALDH1A1 (0.43) ALDH1A1HSD17B10NT5ETSHRTDP1
SCHEMBL16272782 0.64 CYP3A4 (0.35) ALDH1A1HSD17B10TSHRTDP1TP53
SCHEMBL11310899 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101115755-B Pyrazolo-pyrimidine derivatives as MGLUR2 antagonists HOFFMANN LA ROCHE 2013-01-16 CN disclosed
US-7361659-B2 Pyrrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-04-22 US disclosed
CN-101115755-A Pyrazolo-pyrimidine derivatives as MGLUR2 antagonists HOFFMANN LA ROCHE (CH) 2008-01-30 CN disclosed
EP-1851225-A1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2007-11-07 EP disclosed
US-20060183756-A1 Pyrrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2006-08-17 US disclosed
WO-2006084634-A1 PYRAZOLO-PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-08-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183756-A1 Pyrrazolo-pyrimidine derivatives GRM1, GRM2, GRM3 ALDH1A1 617/4885HSD17B10 2867/4885NT5E 2557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.